Dr. Saveen Semage re-appointed as CEO of NMRA
The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Sri Lanka’s security chiefs instructed to ensure safety during Presidential Election July 26, 2024
- Sri Lankan Prime Minister says President cannot appoint acting IGP July 26, 2024
- Bonds placed for Ranil Wickremesinghe to contest Sri Lanka’s Presidential Election July 26, 2024
- Sri Lanka announces 2024 Presidential Election date July 26, 2024
- 22% of Sri Lankan households in debt; 14.2% job losses from economic crisis July 25, 2024